Azelon Therapeutics' Series C Round

Azelon Therapeutics raised a round of funding on August 17, 2011.

Azelon Pharmaceuticals, formerly Zelos Therapeutics, is developing a nasal spray formulation of teriparatide for the treatment of osteoporosis.…

Articles about Azelon Therapeutics' Series C Round: